Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2013
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide VaccineShigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, et al.
Human Vaccines & Immunotherapeutics|February 5, 2013
Current status of immunotherapy for the treatment of biliary tract cancerRyuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, et al.
Biomedicines|October 23, 2021
Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic CancerErica Yada, Rika Kasajima, Atsushi Niida, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2023
Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancerDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
The Journal of Experimental Medicine|June 5, 2002
Involvement of the TCR Cbeta FG loop in thymic selection and T cell functionTetsuro Sasada, Maki Touma, Hsiu-Ching Chang, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapyDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Cancer Science|July 21, 2007
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapyKoichi Azuma, Yoshihiro Komohara, Tetsuro Sasada, et al.
Cancer Medicine|September 15, 2023
Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitorsDaiki Murata, Koichi Azuma, Norikazu Matsuo, et al.
Chemotherapy|January 22, 2025
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung CancerDaiki Murata, Koichi Azuma, Yuuya Nishii, et al.
The Prostate|September 21, 2011
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapyMasanori Noguchi, Fukuko Moriya, Shigetaka Suekane, et al.
Pageof 14